Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients

Journal of Gastroenterology

Volumn 33, Issue 4, 1998, Pages 529-535

  Miyakawa, Hiroshi ^a   Matsushima, Hiroshi ^b   Narita, Yoichi ^b   Hankins, Raleigh W ^b   Kitazawa, Eriko ^a   Fujikawa, Hirotoshi ^a   Kikuchi, Kentaro ^a   Matsushita, Masanao ^a   Abe, Kazuhiro ^a   Kawaguchi, Naomi ^a   Morizane, Toshio ^c   Kako, Makoto ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b Health Sciences Research Institute   (Japan)

^c KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

Anti liver kidney microsome 1(LKM 1); Antigenic epitope; Cytochrome P450 IID6 (CYP2D6)

Indexed keywords

AUTOANTIBODY; CYTOCHROME P450; HYBRID PROTEIN; KIDNEY ANTIBODY; MICROSOME ANTIBODY;

ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DNA LIBRARY; GENE DELETION; HEPATITIS C; HUMAN; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; CYTOCHROME P-450 CYP2D6; DNA PRIMERS; DNA, COMPLEMENTARY; EPITOPES; FEMALE; HEPATITIS C, CHRONIC; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOBLOTTING; JAPAN; MALE; POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE;

EID: 7344239302     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050127     Document Type: Article

References (27)

1. Rizzetto M, Bianchi FB, Doniach D. Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology 1973;26:589-601.
2. Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: A second type of "autoimmune hepatitis". Hepatology 1987;7: 1333-1339.
3. Homberg JC, Andre C, Abuaf N. A new anti-liver-kidney microsome antibody (anti-LKM-2) in tienilic acid-induced hepatitis. Clin Exp Immunol 1984;55:561-570.
4. Crivelli O, Lavarini C, Chiaberge E, et al. Microsomal autoantibodies in chronic infection with the HBs-Ag associated delta(δ) agent. Clin Exp Immunol 1983;54:232-238.
5. Michel G, Ritter A, Gerken G, et al. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992;339:267-269.
6. Lenzi M, Ballardini G, Fusconi M, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990;335:258-259.
7. Garson JA, Lenzi M, Ring C, et al. Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol 1991;34:223-226.
8. Miyakawa H, Kako M, Nagai K, et al. HCV-RNA in type 2 autoimmune hepatitis. Am J Gastroenterol 1991;86:1688-1689.
9. Todros L, Touscoz G, D'Urso N, et al. Hepatitis C virus-related chronic liver disease with autoantibodies to liver/kidney microsomesy (LKM). Clinical characterization from idiopathic LKM-positive disorders. J Hepatol 1991;13:128-131.
10. Nishioka M, Morshed SA, Kono K, et al. Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. J Hepatol 1997;26:992-1000.
11. Strassberg CP, Manns MP. Autoimmune hepatitis versus viral hepatitis C. Liver 1995;15:225-232.
12. Manns MP, Johnson EF, Griffin LJ, et al. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 1989;83:1066-1072.
13. Gonzalez FJ, Shoda RC, Kimura S, et al. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 1988;331:442-446.
14. Gueguen M, Boniface O, Bernard O, et al. Identification of the main epitope on human cytochrome P450IID6 recognized by anti-liver kidney microsome antibody. J Autoimmun 1991;4:607-615.
15. Yamamoto AM, Cresteil D, Boniface O, et al. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodiesy (LKM1). Eur J Immunol 1993;23:1105-1111.
16. Manns MP, Griffin K, Sullivan KF, et al. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991;88:1370-1378.
17. Yamamoto AM, Cresteil D, Homberg JC, et al. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera. Gastroenterology 1993; 104:1762-1767.
18. Miyakawa H, Kitazawa E, Abe K, et al. Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis. J Gastroenterol 1997;32:769-776
19. Okamoto H, Osada S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990;60:1105-1113.
20. Kaufman DL, Evans GA. Restriction endonuclease cleavage at the termini of PCR products. Biotechniques 1990;9:304-306.
21. Sambrook J, Fritsh EF, Maniatis T. Molecular cloning. 2nd ed. New York: Cold Spring Harbor Laboratory Press. 1989;53-73.
22. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-5467.
23. Towbin H, Staehelin H, Gorden J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellurose sheets. Proc Natl Acad Sci USA 1979;76:4350-4354.
24. Todros L, Saracco G, Durazzo M, et al. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology 1995;22:1374-1378.
25. Calleja JL, Albillos A, Carcho G, et al. Interferon and prednisolone therapy in chronic hepatitis C with non-organ-specific antibodies. J Hepatol 1996;24:308-312.
26. Vento S, Cainelli F, Concia E, et al. Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C. J Hepatol 1997;26:955-956.
27. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987;50:819-820.